Arrient Healthcare Pvt Ltd
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.3mg)
Glimpure MV 1.3 Tablet is a combination of anti-diabetic drugs used to treat type 2 diabetes mellitus in adults, helping to control blood sugar levels.
Tablet
Glimpure MV 1.3 Tablet is a combination of three antidiabetic medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Glimpure MV 1.3 Tablet is to be taken empty stomach.
No common side effects listed.
It is unsafe to consume alcohol with Glimpure MV 1.3 Tablet.
Glimpure MV 1.3 Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Glimpure MV 1.3 Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Glimpure MV 1.3 Tablet is a combination of three antidiabetic medicines.
Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol or if you delay or miss a meal. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).
Glimpure MV 1.3 Tablet contains Glimepiride, Metformin, and Voglibose, which are medications used to treat type 2 diabetes mellitus (DM). This combination helps manage blood glucose levels by improving insulin activity and lowering glucose production. It is taken along with a healthy diet and exercise routine for optimal effectiveness.
Common side effects associated with Glimpure MV 1.3 Tablet include hypoglycemia (low blood sugar), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash, and respiratory tract infection.
Glimpure MV 1.3 Tablet is contraindicated in patients with known allergies to any of its components or excipients. It also carries a risk for those with moderate to severe kidney disease, inflammatory bowel disease, ulcerative colitis, and underlying metabolic acidosis including diabetic ketoacidosis.
No, the combined use of Glimpure MV 1.3 Tablet with alcohol is not recommended. It can lead to hypoglycemia (low blood sugar) and potentially increase the risk of lactic acidosis.
Yes, using Glimpure MV 1.3 Tablet can lead to hypoglycemia (low blood sugar). This may manifest as nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feeling anxious or shaky. It's crucial to monitor your blood sugar levels regularly, especially if you miss meals, consume alcohol, overexercise, or take other antidiabetic medications simultaneously.
Store Glimpure MV 1.3 Tablet in its original package or container, tightly sealed. Refer to the product label and packaging for specific storage instructions. If unused medication is left, dispose of it according to local regulations. Ensure that it's not accessible to pets, children, and others.